The impact of COVID-19 has been disproportionate and unequal across different countries, communities and groups of people. Health inequities and ethical challenges affect access to medicines (including vaccination), medicine shortages, and patient selection.
It has recently been reported that, up to December 2021, COVID-19 vaccines averted 19.8m deaths, but less than 1% of these were in low-income countries.* It is advocated that improvements must be made in vaccine distribution, vaccine donations, vaccines intellectual property, vaccine distribution and delivery infrastructure to reach WHO and COVAX vaccination coverage targets and help ensure that vaccines are more equitably distributed in the future.
* Watson OJ et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. The Lancet Infectious Diseases. 23 June 2022. doi.org/10.1016/S1473-3099(22)00320-6
|11:00 – 11:10||Introduction by the chair|
|11:10 – 11:25||
|Vaccine Hesitancy and Vaccine Administration by Pharmacists: Lessons from COVID-19
Mrs Jocelyn Chaibva, African Pharmaceutical Forum, Zimbabwe
|11:25 – 11:40||
|Pharmacy transformation in Egypt
Dr Wael Ali, Egyptian Organisation of Pharmacy, Egypt
|11:40 – 12:20||Panel discussion and Q&A|
|12:20 – 12:30||
Conclusion by the chair
- To discuss the impact of COVID-19 on vulnerable populations in all parts of the world in terms of protection from ongoing circulation of the virus and from other major diseases that continue to disproportionately affect them
- To present solutions and a range of actions to address the basic needs of vulnerable populations during COVID-19 challenges